Combination Covid-19 + Universal Influenza Vaccine: Vivaldi Biosciences Files Patent Application
by Press Release from Outbreak News Today on (#5ARV8)
By NewsDesk @bactiman63 Vivaldi Biosciences, a clinical-stage biotechnology company developing genetically engineered intranasal vaccines for viral respiratory diseases, today announced it has filed a provisional patent application with the US Patent and Trademark Office for its Delta-19 combination vaccine for protection against SARS-CoV-2 (the virus responsible for Covid-19) and all strains of influenza virus. Simultaneous circulation of SARS-CoV-2 and influenza is [...]
The post Combination Covid-19 + Universal Influenza Vaccine: Vivaldi Biosciences Files Patent Application appeared first on Outbreak News Today.